Ameriprise Financial Inc Horizon Therapeutics Public LTD CO Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $60.1 Million - $70.2 Million	-606,784 Reduced 83.44%	120,430 $13.9 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $45.8 Million - $53.4 Million	474,912 Added 188.23%	727,214 $74.8 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $190 Million - $201 Million	-1,774,419 Reduced 87.55%	252,302 $27.5 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $65.1 Million - $119 Million	-1,043,852 Reduced 34.0%	2,026,721 $231 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $29.6 Million - $42.5 Million	501,561 Added 19.52%	3,070,573 $189 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $99.1 Million - $145 Million	1,248,021 Added 94.48%	2,569,012 $204 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $70.6 Million - $89.7 Million	-817,142 Reduced 38.22%	1,320,991 $139 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $41.1 Million - $50 Million	-417,027 Reduced 16.32%	2,138,133 $230 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $21.3 Million - $25.6 Million	-231,616 Reduced 8.31%	2,555,160 $280 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $4.87 Million - $5.41 Million	56,449 Added 2.07%	2,786,776 $261 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $92.2 Million - $123 Million	1,283,244 Added 88.68%	2,730,327 $252 Million
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $7.03 Million - $8.86 Million	-104,930 Reduced 6.76%	1,447,083 $106 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $9.06 Million - $13.1 Million	164,073 Added 11.82%	1,552,013 $121 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $19.7 Million - $37.1 Million	-651,243 Reduced 31.94%	1,387,940 $77.5 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $30.3 Million - $47 Million	-1,218,599 Reduced 37.41%	2,039,183 $60.4 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $6.44 Million - $9.29 Million	-253,315 Reduced 7.21%	3,257,782 $118 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $2.26 Million - $2.74 Million	98,076 Added 2.87%	3,511,097 $95.7 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $77.9 Million - $97.2 Million	3,413,021 New	3,413,021 $82.1 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account